1. Suppression of DDR1 contributes to cancer progression in mammary carcinoma cells. Kamohara H, Ishiko T, Yoshimura T, Baba H AACR Annual Meeting 200

Size: px

Start display at page:

Download "1. Suppression of DDR1 contributes to cancer progression in mammary carcinoma cells. Kamohara H, Ishiko T, Yoshimura T, Baba H AACR Annual Meeting 200"

河洛凤
4 years ago
Views:

1 1. Suppression of DDR1 contributes to cancer progression in mammary carcinoma cells. Kamohara H, Ishiko T, Yoshimura T, Baba H AACR Annual Meeting 2007 April 14-18, 2007, Ros Angels, USA 2. Improved isolation of exfoliated cells from feces for noninvasive diagnosis of colorectal cancer: A comparative study of new immune-magnetic beads Koga Y, Matsushita H, Yasunaga M, Baba H, Matsumura Y AACR Annual Meeting 2007 April 14-18, 2007, Ros Angels, USA 3. A multimodality treatment for resectable pancreatic cancer. Takamori H, Kanemitsu K, Chikamoto A, Ishiko T, Beppu T, Hirota M, Baba H 2007 ASCO Annual Meeting June1-5, 2007, Chicago, USA 4. Radiofrequency ablatuin(rfa) is equivalent in therapeutic effect but safer compared to microwave coagulation therapy(mct) for hepatocellular carcinoma. Beppu T, Masuda T, Ishiko T, Hayashi H, Sugiyama S, Doi K, Takamori H, Kanemitsu K, Hirota M, Baba H 2007 ASCO Annual Meeting June1-5, 2007, Chicago, USA 5. Doubling time of preoperative serum alpha-fetoprotein level can predict recurrence and prognosis after hepatic resection of hepatocellular carcinoma. Masuda T, Beppu T, Ishiko T, Mizumoto H, Hayashi H, Horlad H, Takamori H, Kanemitsu K, Hirota M, Baba H 2007 ASCO Annual Meeting June1-5, 2007, Chicago, USA 6. Clinical benefit of liver hanging maneuver for right-side major hepatectomy. Hayashi H, Beppu T, Nasu J, Masuda T, Mizumoto T, Ishiko T, Takamori H, Kanemitsu K, Hirota M, Baba H 2007 ASCO Annual Meeting June1-5, 2007, Chicago, USA 7. Identification of the bona-fide marker of isolated tumor cell in gastric cancer cases to predict metastasis in terms of tumor side and host side.iwatsuki M, Mimori K, Baba H 6th Internatinal Symposium on Minimal Residual Cancer September17-22, 2007, Hamburg, Germany 8. Rapid genetic diagnosis with the transcription reverse-transcription concerted reaction (TRC) method is useful for detection of a few gastrointestinal cancer cells with carcinoembryonic antigen (CEA) mrna. Imamura Y, Hayashi N, Hiyoshi Y, Nagai Y, Honda S, Toyama E, Miyanari N, Baba H AACR-NCI-EORTC International conference, Molecular Targets and Cancer Therapeutics Oct 22-26, San Fransisco, USA 9. Silvelestat suppresses cancer progression in human pancreatc carcinoma cells. Kamohara H, Sugita H, Takamori H, Hirota M, Baba H AACR-NCI-EORTC International conference, Molecular Targets and Cancer Therapeutics Oct 22-26, San Fransisco, USA 10. The expression of type collagen 6 chain is related to the prognosis in patients with esophageal squamous cell carcinoma. Baba Y, Iyama K, Baba H 7th Panpacific Connective Tissue Conference Oct 28-Nov 1, 2007, Cairns, Australia CPT Neoadjuvant Randomized Phase Traial: (TASC) FOLFOX Kumamoto Clinical Oncology K-COM ICU Silvelestat

2 MP Non-occlusive mesenteric ischemia and its associated intestinal gangrene in severe acute pancreatitis; Clinical features and treatment strategies. Ida S, Baba H IPMN SPARC Serected protein acidic and rich in cysteine E-PASS CRAd - Triple infection Rad18 statusm T MP Hanging maneuver New device

3 LADG HSP Doubling Time PSE HOX DNA Serine protease inhibitor Kazal type 1(SPINK1) nitroguanine Ethanolamine oleate MCN SOX2 SUMO CEA FOLFOX dysplasia FOLFOX

4 adjuvant FOLFOX GI Ehime Cancer Symposium Hanging maneuver new device sirna/liposome complex 23 DDS doubling time PET E-PASS scoring system RFA FOLFOX- neoadjuvant chemotherapy soluble E-Selecin, Thrembomodulin CT

5 85. Pancreatic intraepithelial neoplasia Cre/IoxP+CRAd FOLFOX New Strategy SPARC CEA FOLFOX FOLFOX salvuage retropancreatic tissue FU CDHP Radiation Chop / Psti double knockout mouce -

6 StageIVa FOLFOX LADG FOLFOX doubling time The therapy of unresectable hilar bile duct carcinoma due to the survival term PET

7 cm septic shock severe sepsis C FOFOX E-PASS scoring system Stage a Prognostic node navigation FOLFOX Surgical Oncology Forum Hanging maneuver precoagulation Vp Schwannoma PSE Thermal ablation

8 155. GIST GIST nd line GIST 3 GIST New Evidence TXT+TS Differential expression of basement membrane type Collagen Chains in gastric inramucosal neoplastic lesions. Baba Y, Ishikawa S, Hayashi N, Baba H Silvelestat suppresses cancer progression in human pancreatc carcinoma cells. Kamohara H, Sugita H, Takamori H, Hirota M, Baba H CDH3 a novel cancer associated antigen useful for immunotherapy of pancreatic cancer. Imai K, Hirota S, Ikuta Y, Senju S, Yokomori K, Harao M, Tsunoda T, Nakatsura S, Nakagawa H, Nakamura Y, Baba H, Nishimura Y A comparative study of new immuno-magnetic beads for isolation of exfoliated cells from fces. Koga Y, Yasunaga M, Baba Y, Matsumura Y vs - 26 Microwave Surgery Bio-plex protein array SIRS (DSOF) sepsis Clinical benefit PET(SUVmax) retroperitoneal margin Neoadjuvant Chemotherapy CA (Vp3) PTPE FOLFOX4 1st-line Na FOLFOX

9 E-PASS scoring system (PTPE) ARDS Ce.Ut SIRS CTL Glipican SSI Colorectal Cancer Symposium in Kyoto Colorectal Cancer Forum Identification of a novel cncer-associated antigen CDH3 as a candidate of target for immunotherapy of pancreatic cancer. Imai k, Hirota S, Ikuta Y, Senju S, Yokomine K, Harao M, Tsunoda T, Nakatsura S, Nakagawa H, Nakamura Y, Baba H, Nishimura Y FFP strategy

10 GIST(Gastrointestinal Stromal Tumors) AFP Adjuvant Adjuvant Chemotherapy Meeting th Kyushu Oncology Forum(KOF) GI JAPAN KOREA DIF Meeting GIST Treatment Strategy Summit Advisory Board Meeting

11 SIRS ACTS RC ()

1. Endoscopic surgery is less invasive and can provide a favorable long-term survival in patients with hepatocellular carcinoma compared to convention

1. Endoscopic surgery is less invasive and can provide a favorable long-term survival in patients with hepatocellular carcinoma compared to conventional hepatectomy. Komori H, Beppu T, Horino K, Masuda